China SFDA Approves Clinical Trials To Combat Antibiotic Resistant Infection

Haikou based China Pharma Holdings,has received approval from China's State Food and Drug Administration to start clinical trials of a combination of an antibiotic with a bacterial-enzyme inhibitor. The company.....

Subscribe for Full Access!

Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
Subscribe!
Share this Data